PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human CCL19 (MIP-3β) (carrier-free), 25 μg
Recombinant Human CCL19 (MIP-3β) (carrier-free), 500 μg
Recombinant Human CCL2 (MCP-1) (Animal-Free), 20 μg
Recombinant Human CCL2 (MCP-1) (carrier-free), 10 μg
Recombinant Human CCL2 (MCP-1) (carrier-free), 100 μg
Recombinant Human CCL2 (MCP-1) (carrier-free), 25 μg
Recombinant Human CCL2 (MCP-1) (carrier-free), 500 μg
Recombinant Human CCL20 (MIP-3α) (carrier-free), 10 μg
Recombinant Human CCL20 (MIP-3α) (carrier-free), 25 μg
Recombinant Human CCL20 (MIP-3α) (ELISA Std.), 4 pack
Recombinant Human CCL21 (6CKine) (carrier-free), 10 μg
Recombinant Human CCL21 (6CKine) (carrier-free), 100 μg
Recombinant Human CCL21 (6CKine) (carrier-free), 25 μg
Recombinant Human CCL21 (6CKine) (carrier-free), 500 μg
Recombinant Human CCL22 (MDC) (carrier-free), 10 μg
Recombinant Human CCL22 (MDC) (carrier-free), 25 μg